Concepedia

Author

Konstantinos Zervas

National and Kapodistrian University of AthensORCID

Also Known As

I Tsiamalou, K Zervas, K. Zervas, Konstantinos Zervas, V Markatou, Zervas K, Zervas Konstantinos

103

Publications

4K

Citations

31

H-Index

56

Concepts

All Affiliations

National and Kapodistrian University of AthensTheageneio General HospitalSt Savas HospitalGeneral Hospital of Athens G. GenimatasUniversity of Patras
KZ

About

Konstantinos Zervas is an author at National and Kapodistrian University of Athens specializing in medicine, hematology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

27

1.7K

2

Health Sciences

11

11

616

3

Public Health

1

1

15

4

Cell Biology

1

1

20

5

Gastroenterology

1

1

25

Konstantinos Zervas

×

44

Publications

3.4K

Citations

28

H-Index

YearCitations

Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw

Konstantinos Vahtsevanos, Αthanassios Kyrgidis, Evgenia Verrou,

Journal of Clinical Oncology

2009

461

Thalidomide and dexamethasone combination for refractory multiple myeloma

Meletios Α. Dimopoulos, Konstantinos Zervas, G. Kouvatseas,

Annals of Oncology

2001

282

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

James Glasbey, Adesoji Ademuyiwa, Adewale Adisa,

The Lancet Oncology

2021

280

Primary Treatment of Waldenström Macroglobulinemia With Dexamethasone, Rituximab, and Cyclophosphamide

Meletios Α. Dimopoulos, Athanasios K. Anagnostopoulos, Marie‐Christine Kyrtsonis,

Journal of Clinical Oncology

2007

277

Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance

V. Eleutherakis-Papaiakovou, Aristotelis Bamias, Dimitra Gika,

Leukemia & lymphoma/Leukemia and lymphoma

2007

223

Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG)

Efstathios Kastritis, Konstantinos Zervas, Argiris Symeonidis,

Leukemia

2009

187

Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: Reduction post‐bortezomib monotherapy

Evangelos Terpos, Dimitrios Christoulas, Eirini Katodritou,

International Journal of Cancer

2011

180

High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents

Evangelos Terpos, Eirini Katodritou, Anastasia Pouli,

European Journal Of Haematology

2010

144

Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone(T-VAD doxil): a phase II multicenter study

Konstantinos Zervas, Meletios Α. Dimopoulos, E Hatzicharissi,

Annals of Oncology

2003

118

The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio

Evangelos Terpos, Dimitra Mihou, Richard Szydlo,

Leukemia

2005

102

Page 1